Literature DB >> 108257

Purification and characterization of smooth and rough lipopolysaccharides from Brucella abortus.

E Moreno, M W Pitt, L M Jones, G G Schurig, D T Berman.   

Abstract

In an attempt to obtain pure and well characterized smooth lipopolysaccharide (S-LPS) and rough lipopolysaccharide (R-LPS), smooth and rough strains of Brucella abortus were extracted by two different modifications of the phenol-water method. S-LPS was obtained in the phenol phase, and R-LPS was obtained in the aqueous phase. Further purification was accomplished by treatment with enzymes, detergents, NaI as a chaotropic agent to separate non-covalently bound contaminants, and by gel filtration. The degree of purity of the molecules was determined by chemical and immunological analysis and by electrophoresis in sodium dodecyl sulfate-polyacrylamide gels. Lipid identification by gas-liquid chromatography showed seven major fatty acids. Palmitic acid accounts for about 50%, stearic acid accounts for about 10%, and hydroxylated fatty acids account for less than 5% of total fatty acids. 2-Keto-3-deoxyoctonate but not heptose was detected in the sugar analysis. Protein was found to be firmly bound to S-LPS but not to R-LPS.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 108257      PMCID: PMC218186          DOI: 10.1128/jb.138.2.361-369.1979

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  37 in total

1.  Biological and physicochemical properties of the lipopolysaccharide of Chromatium vinosum.

Authors:  R E Hurlbert; I M Hurlbert
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

2.  Chemo-taxonomical studies on fatty acids of "Brucella" species.

Authors:  S Tanaka; T Suto; Y Isayama; R Azuma; H Hatakeyama
Journal:  Ann Sclavo       Date:  1977 Jan-Feb

3.  Heterogeneity of lipopolysaccharides. Analysis of polysaccharide chain lengths by sodium dodecylsulfate-polyacrylamide gel electrophoresis.

Authors:  B Jann; K Reske; K Jann
Journal:  Eur J Biochem       Date:  1975-12-01

4.  Antibody response to antigens distinct from smooth lipopolysaccharide complex in Brucella infection.

Authors:  G G Schurig; L M Jones; S L Speth; D T Berman
Journal:  Infect Immun       Date:  1978-09       Impact factor: 3.441

5.  SDS-polyacrylamide gel electrophoresis of lipopolysaccharides.

Authors:  R R Russell; K G Johnson
Journal:  Can J Microbiol       Date:  1975-12       Impact factor: 2.419

6.  Physical state and biological activity of lipopolysaccharides. Toxicity and immunogenicity of the lipid A component.

Authors:  C Galanos
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1975-07

7.  Endotoxic activity of rough organisms of Brucella species.

Authors:  L M Jones; R Diaz; D T Berman
Journal:  Infect Immun       Date:  1976-06       Impact factor: 3.441

8.  Biochemical basis of the serological cross-reactions between Brucella abortus and Yersinia enterocolitica serotype O:9.

Authors:  A Marx; R Sandulache; A Pop; A Cerbu
Journal:  Ann Microbiol (Paris)       Date:  1975-12

9.  Comparison of the histamine hypersensitivity and the Limulus amoebocyte lysate tests for endotoxin activity.

Authors:  J J Munoz; R K Bergman; K E Robbins
Journal:  Infect Immun       Date:  1978-10       Impact factor: 3.441

10.  Studies on the chemical composition of lipopolysaccharide from Neisseria meningitidis group B.

Authors:  G A Limjuco; Y D Karkhanis; J Y Zeltner; R Z Maigetter; J J King; D J Carlo
Journal:  J Gen Microbiol       Date:  1978-02
View more
  64 in total

1.  Influence of endotoxin-protein in immunoglobulin G isotype responses of mice to Brucella abortus lipopolysaccharide.

Authors:  R S Kurtz; D T Berman
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

2.  Purification of nonlipopolysaccharide antigen from Brucella abortus during preparation of antigen used for indirect hemolysis test.

Authors:  E M Hoffmann; J J Houle
Journal:  J Clin Microbiol       Date:  1986-11       Impact factor: 5.948

3.  Role of Toll-like receptor 4 in induction of cell-mediated immunity and resistance to Brucella abortus infection in mice.

Authors:  Marco A Campos; Gracia M S Rosinha; Igor C Almeida; Xirlene S Salgueiro; Bruce W Jarvis; Gary A Splitter; Nilofer Qureshi; Oscar Bruna-Romero; Ricardo T Gazzinelli; Sergio C Oliveira
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

4.  Immunochemical characterization of rough Brucella lipopolysaccharides.

Authors:  E Moreno; L M Jones; D T Berman
Journal:  Infect Immun       Date:  1984-03       Impact factor: 3.441

5.  Absence of lipopolysaccharide in the Lyme disease spirochete, Borrelia burgdorferi.

Authors:  K Takayama; R J Rothenberg; A G Barbour
Journal:  Infect Immun       Date:  1987-09       Impact factor: 3.441

6.  Unusual fatty acid substitution in lipids and lipopolysaccharides of Helicobacter pylori.

Authors:  G Geis; H Leying; S Suerbaum; W Opferkuch
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

7.  Effect of Brucella abortus lipopolysaccharide on oxidative metabolism and lysozyme release by human neutrophils.

Authors:  O Rasool; E Freer; E Moreno; C Jarstrand
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

8.  Lipopolysaccharide (LPS) from Brucella abortus is less toxic than that from Escherichia coli, suggesting the possible use of B. abortus or LPS from B. abortus as a carrier in vaccines.

Authors:  J Goldstein; T Hoffman; C Frasch; E F Lizzio; P R Beining; D Hochstein; Y L Lee; R D Angus; B Golding
Journal:  Infect Immun       Date:  1992-04       Impact factor: 3.441

9.  Induction of immune and adjuvant immunoglobulin G responses in mice by Brucella lipopolysaccharide.

Authors:  E Moreno; R S Kurtz; D T Berman
Journal:  Infect Immun       Date:  1984-10       Impact factor: 3.441

10.  Antigenic S-type lipopolysaccharide of Brucella abortus 1119-3.

Authors:  M Caroff; D R Bundle; M B Perry; J W Cherwonogrodzky; J R Duncan
Journal:  Infect Immun       Date:  1984-11       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.